- TNF-a-Inhibition Improves the Biocompatibility of Porous Polyethylene Implants In Vivo
-
Hussain T, Gellrich D, Siemer S, Reichel CA, Eckrich J, Dietrich D, Knauer SK, Stauber RH, Strieth S
- KMID: 2514874
- Tissue Eng Regen Med.
- 2021 Apr;18(2):297-303.
- doi: 10.1007/s13770-020-00325-w
BACKGROUND: To improve the biocompatibility of porous polyethylene (PPE) implants and expand their application range for reconstructive surgery in poorly vascularized environments, implants were coated with tumor necrosis factor a... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Tumor Necrosis Factor-Alpha Inhibitors on Uveitis in Patients with Ankylosing Spondylitis
-
Lee S, Park YJ, Lee JY
- KMID: 2461174
- J Korean Med Sci.
- 2019 Nov;34(42):e278.
- doi: 10.3346/jkms.2019.34.e278
BACKGROUND: Tumor necrosis factor-alpha (TNF-α) inhibitors (TNFis), which are the main treatment for ankylosing spondylitis (AS), have been reported not only to reduce the incidence of anterior uveitis (AU) but... -
- CITED
-
- Close
- SHARE
-
- Close
- Long Term Safety and Efficacy of Etanercept in Juvenile Idiopathic Arthritis in a Single Center
-
Bang MH, Kim KN
- KMID: 2451512
- J Rheum Dis.
- 2019 Jul;26(3):200-205.
- doi: 10.4078/jrd.2019.26.3.200
OBJECTIVE: Our aim was to investigate the long term safety and efficacy of etanercept in children with juvenile idiopathic arthritis (JIA). METHODS: The study subjects were the 90 JIA patients treated... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-World Experience with Etanercept Therapy and the Switching Pattern among Korean Patients with Psoriasis after Withdrawal of Etanercept
-
Choi CW, Lee JS, Yu DA, Kim BR, Youn SW
- KMID: 2430800
- Ann Dermatol.
- 2019 Feb;31(1):44-50.
- doi: 10.5021/ad.2019.31.1.44
BACKGROUND: The efficacy and safety of etanercept in the treatment of psoriasis has been proven, and the drug was approved for the treatment of moderate to severe psoriasis. However, there... -
- CITED
-
- Close
- SHARE
-
- Close
- Tumor Necrosis Factor Alpha Blocker-Induced Erythrodermic Sarcoidosis in with Juvenile Rheumatoid Arthritis: A Case Report and Review of the Literature
-
Park SK, Hwang PH, Yun SK, Kim HU, Park J
- KMID: 2368031
- Ann Dermatol.
- 2017 Feb;29(1):74-78.
- doi: 10.5021/ad.2017.29.1.74
The development of cutaneous sarcoidosis as a paradoxical adverse event of tumor necrosis factor alpha (TNF-α) blockers has been reported in the literature; however, an erythrodermic form of cutaneous sarcoidosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Dose Optimization for Single Intradiscal Administration of the Tumor Necrosis Factor-α Inhibitor, Etanercept, in Rat Disc Injury Models
-
Inage K, Orita S, Yamauchi K, Suzuki T, Suzuki M, Sakuma Y, Kubota G, Oikawa Y, Sainoh T, Sato J, Fujimoto K, Shiga Y, Abe K, Kanamoto H, Inoue M, Kinoshita , Takahashi , Ohtori S
- KMID: 2349282
- Asian Spine J.
- 2016 Aug;10(4):619-623.
- doi: 10.4184/asj.2016.10.4.619
STUDY DESIGN: Experimental animal study. PURPOSE: We aimed to determine the optimal dose of a single direct injection of the tumor necrosis factor (TNF)-α inhibitor, etanercept, by using the rat model... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Sarcoidosis That Improved upon Discontinuation of Etanercept
-
Kang JH, Ahn JH, Yu JE, Kim JE, Yim YR, Lee JW, Lee KE, Park DJ, Wen L, Park YW, Lee SS
- KMID: 2326735
- J Rheum Dis.
- 2016 Jun;23(3):187-192.
- doi: 10.4078/jrd.2016.23.3.187
A 31-year-old man who had been prescribed etanercept over a 3-year period for treatment of ankylosing spondylitis presented with newly developed dry cough, chills, myalgia, and weight loss. Chest computed... -
- CITED
-
- Close
- SHARE
-
- Close
- Nodular Vasculitis That Developed during Etanercept (Enbrel) Treatment in a Patient with Psoriasis
-
Park SB, Chang IK, Im M, Lee Y, Kim CD, Seo YJ, Lee JH
- KMID: 2171462
- Ann Dermatol.
- 2015 Oct;27(5):605-607.
- doi: 10.5021/ad.2015.27.5.605
Nodular vasculitis was introduced by Montgomery for cases of erythema induratum-like lesions that were not associated with tuberculosis. Nodular vasculitis has been associated with both nontuberculous infections and noninfectious conditions.... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Direct Injection of Etanercept into Knee Joints for Pain in Moderate and Severe Knee Osteoarthritis
-
Ohtori S, Orita S, Yamauchi K, Eguchi Y, Ochiai N, Kishida S, Kuniyoshi , Aoki Y, Nakamura J, Ishikawa T, Miyagi M, Kamoda H, Suzuki M, Kubota G, Sakuma Y, Oikawa Y, Inage K, Sainoh T, Sato J, Shiga Y, Abe K, Fujimoto K, Kanamoto H, Toyone T, Inoue G, Takahashi
- KMID: 2163632
- Yonsei Med J.
- 2015 Sep;56(5):1379-1383.
- doi: 10.3349/ymj.2015.56.5.1379
PURPOSE: Osteoarthritic (OA) pain is largely considered to be inflammatory pain. However, during the last stage of knee OA, sensory nerve fibers in the knee are shown to be significantly... -
- CITED
-
- Close
- SHARE
-
- Close
- Pulmonary Cryptococcosis in a Patient with Ankylosing Spondylitis treated with Etanercept
-
Lim CH, Lee SH, Kim HY, Kim WS, Kang S, Kwon SW, Kim J, Park SY, An SH, Yu HM, Kim HR
- KMID: 2222965
- J Rheum Dis.
- 2014 Aug;21(4):214-218.
- doi: 10.4078/jrd.2014.21.4.214
Ankylosing spondylitis (AS) is a chronic inflammatory disorder, commonly characterized by inflammation of axial skeleton and development of enthesopathies. Tumor necrosis factor inhibitors (TNFi) shows good therapeutic responses in AS... -
- CITED
-
- Close
- SHARE
-
- Close
- Rheumatoid Arthritis with Secondary Amyloidosis and Chronic Kidney Disease with a Good Response to Etanercept
-
Kim HW, Noh JW, Kim J
- KMID: 2223001
- J Rheum Dis.
- 2013 Dec;20(6):389-392.
- doi: 10.4078/jrd.2013.20.6.389
Secondary amyloidosis is a severe complication of refractory rheumatoid arthritis for which no effective treatment exists. Although the benefits of tumor necrosis factor alpha inhibitors in rheumatoid arthritis treatment are... -
- CITED
-
- Close
- SHARE
-
- Close
- Interstitial Lung Disease That Occurred during Treatment with Etanercept (Enbrel(R)) of Psoriasis Patients
-
Park SB, Kim HR, Im M, Lee Y, Seo YJ, Lee JH
- KMID: 2246592
- Korean J Dermatol.
- 2013 Sep;51(9):709-712.
Etanercept is widely used to treat autoimmune rheumatic, digestive, and dermatologic diseases such as psoriasis. It acts as a competitive inhibitor of tumor necrosis factor (TNF)-alpha and has acceptable safety... -
- CITED
-
- Close
- SHARE
-
- Close
- Refractory Plaque Psoriasis Treated with a Combination of Etanercept and Low Dose Methotrexate
-
Lim HS, Yun SJ, Lee JB, Kim SJ, Won YH, Lee SC
- KMID: 2388395
- Korean J Dermatol.
- 2013 Jun;51(6):438-441.
Etanercept has been proven to be highly effective to moderate severe plaque psoriasis. Alternative biologics or combination therapies of etanercept with other systemic agents have been recommended to patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety and Efficacy Evaluation for the Addition of Either Etanercept or Leflunomide in Korean Rheumatoid Arthritis Patients Inadequately Responding to Methotrexate
-
Joo K, Park W, Kwon SR, Lim MJ
- KMID: 2222755
- J Rheum Dis.
- 2013 Jun;20(3):166-171.
- doi: 10.4078/jrd.2013.20.3.166
OBJECTIVE: To compare the safety and efficacy associated with the addition of etanercept (ETN) with that of leflunomide (LEF) in Korean rheumatoid arthritis (RA) patients, who inadequately respond to methotrexate... -
- CITED
-
- Close
- SHARE
-
- Close
- Etanercept Treatment in Ankylosing Spondylitis Hip Lesions
-
Kim YC, Moon SW
- KMID: 2054151
- Hip Pelvis.
- 2013 Jun;25(2):135-140.
- doi: 10.5371/hp.2013.25.2.135
PURPOSE: To evaluate the efficacy of etanercept in patients with an ankylosing spondylitis hip lesion. MATERIALS AND METHODS: Between March 2008 and December 2011, this study evaluated 13 patients with hip... -
- CITED
-
- Close
- SHARE
-
- Close
- Switching to Etanercept in Intestinal Behcet's Disease Complicated by Secondary Non-response to Anti-TNF-alpha Antibodies
-
Lee S, Kim TO, Park CS, Kim HK, Kim SH
- KMID: 2223064
- J Rheum Dis.
- 2012 Dec;19(6):355-358.
- doi: 10.4078/jrd.2012.19.6.355
The efficacy of anti-TNF-alpha antibodies including infliximab and adalimumab for refractory intestinal Behcet's disease has recently been demonstrated in a series of case reports. The efficacy of switching to a... -
- CITED
-
- Close
- SHARE
-
- Close
- Etanercept-induced Leukocytoclastic Vasculitis
-
Kim JH, Shin WU, Baek YS, Oh CH, Kim JH
- KMID: 2247310
- Korean J Dermatol.
- 2012 Sep;50(9):807-809.
Leukocytoclastic vasculitis is a small vessel inflammatory disease mediated mostly by deposition of immune complexes. Etanercept (Enbrel(R)) is widely used not only for rheumatic disorders such as ankylosing spondylitis but... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Macropharge Activation Syndrome Successfully Treated with Combination Therapy Including Etanercept
-
Sim YS, Kim HS, Kim KN
- KMID: 2223076
- J Rheum Dis.
- 2012 Aug;19(4):225-229.
- doi: 10.4078/jrd.2012.19.4.225
Macrophage activation syndrome (MAS) is a severe, potentially life-threatening complication of childhood systemic inflammatory disorder, primarily systemic onset juvenile rheumatoid arthritis (SoJRA). It is characterized by pancytopenia, liver insufficiency, coagulopathy,... -
- CITED
-
- Close
- SHARE
-
- Close
- Juvenile Rheumatoid Arthritis in Children with Ebstein-barr Virus Infection
-
Shim YS, Kim JS, Lee KK, Lee KM, Kim KN
- KMID: 2223115
- J Rheum Dis.
- 2012 Feb;19(1):19-24.
- doi: 10.4078/jrd.2012.19.1.19
OBJECTIVE: Juvenile rheumatoid arthritis (JRA) may occur in the wake of infection with several viruses including Ebstein-barr virus (EBV). EBV remains an interesting target. To determine the possible role of... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Acrodermatitis Continua of Hallopeau Treated with Etanercept
-
Park J, Lee Y, Noh S, Cho S, Park CO, Lee KH
- KMID: 2247517
- Korean J Dermatol.
- 2012 Jan;50(1):92-94.
Acrodermatitis continua of Hallopeau (ACH) is a rare form of acropustular eruption characterized by a presence of aseptic pustules on inflammatory periungual or subungual regions. Frequently accompanied by paronychia, atrophic... -
- CITED
-
- Close
- SHARE
-
- Close
